Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.
Market watch
Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link
Kenvue stock rallied on Tuesday off a record low, after a White House press conference didn’t offer fresh evidence that could be used by plaintiffs to sue the maker of Tylenol for its alleged link to autism.
Major stock exchanges worldwide responded positively to trade agreement developments